Phosphorylation and ubiquitination of the 26S proteasome complex.

Enzyme & protein Pub Date : 1993-01-01 DOI:10.1159/000468690
J D Etlinger, S X Li, G G Guo, N Li
{"title":"Phosphorylation and ubiquitination of the 26S proteasome complex.","authors":"J D Etlinger,&nbsp;S X Li,&nbsp;G G Guo,&nbsp;N Li","doi":"10.1159/000468690","DOIUrl":null,"url":null,"abstract":"<p><p>This article reviews recent studies from our laboratory on protein regulators of the proteasome (multicatalytic proteasome complex) in red blood cells. A 240-kD inhibitory component (CF-2) exists in 26S proteasome complexes in a form which is conjugated to ubiquitin. Interestingly, this factor was shown to be identical to delta-aminolevulinic acid dehydratase (ALAD), involved in heme synthesis. A distinct 200-kD inhibitor of the proteasome is not present in the 26S complex. A 32-kD subunit of the 20S proteasome appears to be important for the latency of this core protease. Multiple isoelectric variants of the 32-kD subunit are consistent with phosphorylation. Another 20S proteasome subunit of 30 kD molecular weight is phosphorylated at specific serine residues by copurifying casein kinase II. It is suggested that ubiquitination and phosphorylation may account for at least part of the ATP dependency associated with the 26S proteasome complex. These modifications may play a role in the activity, assembly, translocation and/or turnover of this particle.</p>","PeriodicalId":11854,"journal":{"name":"Enzyme & protein","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"1993-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000468690","citationCount":"17","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Enzyme & protein","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1159/000468690","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 17

Abstract

This article reviews recent studies from our laboratory on protein regulators of the proteasome (multicatalytic proteasome complex) in red blood cells. A 240-kD inhibitory component (CF-2) exists in 26S proteasome complexes in a form which is conjugated to ubiquitin. Interestingly, this factor was shown to be identical to delta-aminolevulinic acid dehydratase (ALAD), involved in heme synthesis. A distinct 200-kD inhibitor of the proteasome is not present in the 26S complex. A 32-kD subunit of the 20S proteasome appears to be important for the latency of this core protease. Multiple isoelectric variants of the 32-kD subunit are consistent with phosphorylation. Another 20S proteasome subunit of 30 kD molecular weight is phosphorylated at specific serine residues by copurifying casein kinase II. It is suggested that ubiquitination and phosphorylation may account for at least part of the ATP dependency associated with the 26S proteasome complex. These modifications may play a role in the activity, assembly, translocation and/or turnover of this particle.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
26S蛋白酶体复合物的磷酸化和泛素化。
本文综述了近年来我们实验室对红细胞中蛋白酶体(多催化蛋白酶体复合物)蛋白调节因子的研究进展。一个240-kD抑制成分(CF-2)以与泛素结合的形式存在于26S蛋白酶体复合物中。有趣的是,该因子被证明与参与血红素合成的δ -氨基乙酰丙酸脱水酶(ALAD)相同。在26S复合体中不存在明显的200-kD蛋白酶体抑制剂。20S蛋白酶体的32kd亚基似乎对该核心蛋白酶的潜伏期很重要。32-kD亚基的多个等电变异与磷酸化一致。另一个分子量为30 kD的20S蛋白酶体亚基通过酪蛋白激酶II的共硫化在特定丝氨酸残基上磷酸化。这表明,泛素化和磷酸化可能至少部分解释了与26S蛋白酶体复合物相关的ATP依赖性。这些修饰可能在该颗粒的活性、组装、易位和/或周转中起作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Mechanisms controlling the transcription of matrix metalloproteinase genes in normal and neoplastic cells. What structure and function of avian plasminogen activator and matrix metalloproteinase-2 reveal about their counterpart mammalian enzymes, their regulation and their role in tumor invasion. Proteases associated with invadopodia, and their role in degradation of extracellular matrix. Cooperation between matrix metalloproteinases and the plasminogen activator-plasmin system in tumor progression. Urokinase plasminogen activator as a predictor of aggressive disease in breast cancer.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1